Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML

被引：76
|
作者：
Summers, K. [1 ]
Stevens, J.
Kakkas, I.
Smith, M.
Smith, L. L.
MacDougall, F.
Cavenagh, J.
Bonnet, D.
Young, B. D.
机构：
[1] Barts & London Queen Marys Sch Med & Dent, Ctr Med Oncol, London, England
[2] Guys Hosp, Dept Hematol, London, England
[3] St Bartholomews Hosp, Dept Hematol, London, England
[4] Canc Res UK, London Res Inst, Haematopoiet Stem Cell Lab, London, England
来源：
LEUKEMIA | 2007年 / 21卷 / 03期
关键词：
D O I：
10.1038/sj.leu.2404514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [1] Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML
    K Summers
    J Stevens
    I Kakkas
    M Smith
    L L Smith
    F MacDougall
    J Cavenagh
    D Bonnet
    B D Young
    T A Lister
    J Fitzgibbon
    [J]. Leukemia, 2007, 21 : 550 - 551
  • [2] Reply to ‘Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML’ by Summers et al.
    C G Nyvold
    H B Ommen
    M Østergaard
    P Hokland
    [J]. Leukemia, 2007, 21 : 552 - 552
  • [3] Reply to 'Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML' by Summers et al.
    Nyvold, C. G.
    Ommen, H. B.
    Ostergaard, M.
    Hokland, P.
    [J]. LEUKEMIA, 2007, 21 (03) : 552 - 552
  • [4] Wilm's tumour 1 (WT1) mutations are associated with FLT3-ITD mutation and poor prognosis in normal karyotype AML.
    Fitzgibbon, Jude
    Summers, Karin
    Kakkas, Ioannis
    Stevens, Jane
    Smith, Matthew
    Smith, Lan-Lan
    Molloy, Gael
    McDougal, Finlay
    Bonnet, Dominique
    Young, Bryan D.
    Andrew Lister, T.
    [J]. BLOOD, 2006, 108 (11) : 652A - 652A
  • [5] FLT3-ITD but not FLT3-TKD mutations have major prognostic impact in normal karyotype AML
    Schneider, Stephanie
    Schneider, Friederike
    Dufour, Annika
    Mellert, Gudrun
    Zellmeier, Evelyn
    Braess, Jan
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Fritsch, Susanne
    Heinecke, Achim
    Sauerland, Maria C.
    Hoster, Eva
    Unterhalt, Michael
    Berdel, Wolfgang E.
    Wormann, Bernhard J.
    Buechner, Thomas
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    [J]. BLOOD, 2007, 110 (11) : 1021A - 1021A
  • [6] Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML.
    Schneider, Friederike
    Hoster, Eva
    Unterhalt, Michael
    Schneider, Stephanie
    Dufour, Annika
    Benthaus, Tobias
    Mellert, Gudrun
    Zellmeier, Evelyn
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Braess, Jan
    Heinecke, Achim
    Sauerland, Maria C.
    Berdel, Wolfgang E.
    Buechner, Thomas
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    [J]. BLOOD, 2008, 112 (11) : 879 - 879
  • [7] Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)
    Friederike Schneider
    Eva Hoster
    Stephanie Schneider
    Annika Dufour
    Tobias Benthaus
    Purvi M. Kakadia
    Stefan K. Bohlander
    Jan Braess
    Achim Heinecke
    Maria C. Sauerland
    Wolfgang E. Berdel
    Thomas Buechner
    Bernhard J. Woermann
    Michaela Feuring-Buske
    Christian Buske
    Ursula Creutzig
    Christian Thiede
    Michel C. Zwaan
    Marry M. van den Heuvel-Eibrink
    Dirk Reinhardt
    Wolfgang Hiddemann
    Karsten Spiekermann
    [J]. Annals of Hematology, 2012, 91 : 9 - 18
  • [8] Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)
    Schneider, Friederike
    Hoster, Eva
    Schneider, Stephanie
    Dufour, Annika
    Benthaus, Tobias
    Kakadia, Purvi M.
    Bohlander, Stefan K.
    Braess, Jan
    Heinecke, Achim
    Sauerland, Maria C.
    Berdel, Wolfgang E.
    Buechner, Thomas
    Woermann, Bernhard J.
    Feuring-Buske, Michaela
    Buske, Christian
    Creutzig, Ursula
    Thiede, Christian
    Zwaan, Michel C.
    van den Heuvel-Eibrink, Marry M.
    Reinhardt, Dirk
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (01) : 9 - 18
  • [9] Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD 1 normal karyotype AML patients
    Libura, Marta
    Giebel, Sebastian
    Piatkowska-Jakubas, Beata
    Pawelczyk, Marta
    Florek, Izabella
    Matiakowska, Karolina
    Jazwiec, Bozena
    Borg, Katarzyna
    Solarska, Iwona
    Zawada, Magdalena
    Czekalska, Sylwia
    Libura, Jolanta
    Jakobczyk, Malgorzata
    Karabin, Karolina
    Paluszewska, Monika
    Calbecka, Malgorzata
    Gajkowska-Kulik, Justyna
    Gadomska, Grazyna
    Kielbinski, Marek
    Ejduk, Anna
    Kata, Dariusz
    Grosicki, Sebastian
    Wierzbowska, Agnieszka
    Kyrcz-Krzemien, Slawomira
    Warzocha, Krzysztof
    Kuliczkowski, Kazimierz
    Skotnicki, Aleksander
    Holowiecki, Jerzy
    Jedrzejczak, Wieslaw Wiktor
    Haus, Olga
    [J]. BLOOD, 2016, 127 (03) : 360 - 362
  • [10] FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype.
    Krauter, Jurgen
    Wagner, Katharina
    Damm, Frederik
    Thol, Felicitas
    Fiedler, Walter
    Ottmann, Oliver G.
    Heit, Wolfgang F. W.
    Luebbert, Michael
    Raghavachar, Aruna
    Goehring, Gudrun
    Heuser, Michael
    Schlegelberger, Brigitte
    Heil, Gerhard
    Ganser, Arnold
    [J]. BLOOD, 2010, 116 (21) : 719 - 720
12345